Document Detail


Physiologic levels of epidermal growth factor in saliva stimulate cell migration of an oral epithelial cell line, HO-1-N-1.
MedLine Citation:
PMID:  12013556     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An oral epithelial cell line derived from buccal mucosa squamous cell carcinoma, HO-1-N-1, was used to elucidate the role of epidermal growth factor (EGF) in saliva on wound healing of the oral mucosa. The effects of EGF on DNA synthesis, and cell migration was studied and the related signal transduction pathways examined. DNA synthesis by HO-1-N-1 cells was stimulated dose-dependently by 1-10 ng ml(-1) EGF, but significantly inhibited by addition of a PI3-K inhibitor (wortmannin), a p38 MAPK inhibitor (SB203580) or an MEKs inhibitor (PD98059). Cell migration was also accelerated by addition of 1-10 ng ml(-1) EGF; however, the migration rate was decreased to 30% by adding PD98059, to 40% by adding a tyrosine kinase inhibitor (herbimycin A), and to 60% by adding wortmannin or dexamethasone. These results indicate that the physiologic concentration of EGF in saliva may stimulate proliferation and migration of oral epithelial cells for wound healing, when the oral mucosa has been injured. Furthermore, this study revealed that EGF-stimulated signal transduction pathways for epithelial cell proliferation and cell migration are different.
Authors:
Mitsuhiro Ohshima; Masashi Sato; Masako Ishikawa; Masao Maeno; Kichibee Otsuka
Related Documents :
10900196 - Single cell ras-gtp analysis reveals altered ras activity in a subpopulation of neurofi...
3500716 - Egf receptors on tea3a1 endocrine thymic epithelial cells.
8392596 - The e5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects t...
3594436 - Overexpression of ras in mucus-secreting human colon carcinoma cells of low tumorigenic...
21671256 - Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter rel...
23252906 - Regulatory t cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of oral sciences     Volume:  110     ISSN:  0909-8836     ISO Abbreviation:  Eur. J. Oral Sci.     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-05-15     Completed Date:  2002-08-12     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9504563     Medline TA:  Eur J Oral Sci     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  130-6     Citation Subset:  D; IM    
Affiliation:
Department of Biochemistry, Nihon University School of Dentistry, Tokyo, Japan. oshima-m@dent.nihon-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Androstadienes / pharmacology
Carcinoma, Squamous Cell
Cell Division
Cell Movement / drug effects,  physiology*
DNA / biosynthesis
Dexamethasone / pharmacology
Enzyme Inhibitors / pharmacology
Epidermal Growth Factor / pharmacology,  physiology*
Epithelial Cells / physiology
Glucocorticoids / pharmacology
Humans
Immunity, Mucosal / physiology*
MAP Kinase Signaling System / drug effects
Mouth Mucosa / physiology*
Mouth Neoplasms
Saliva / chemistry,  physiology*
Salivary Proteins and Peptides / physiology*
Tumor Cells, Cultured
Wound Healing / physiology*
Chemical
Reg. No./Substance:
0/Androstadienes; 0/Enzyme Inhibitors; 0/Glucocorticoids; 0/Salivary Proteins and Peptides; 19545-26-7/wortmannin; 50-02-2/Dexamethasone; 62229-50-9/Epidermal Growth Factor; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of restraint stress on ligature-induced periodontitis in rats.
Next Document:  Osteoblastic activity of the rabbit temporomandibular joint during distraction osteogenesis assessed...